Unknown

Dataset Information

0

Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis.


ABSTRACT: Vascular endothelial growth factor (VEGF) and its receptors are considered the primary cause of tumor-induced angiogenesis. Specifically, VEGFR-2/kinase insert domain receptor (KDR) is part of the major signaling pathway that plays a significant role in tumor angiogenesis, which is associated with the development of various types of tumor and metastasis. In particular, KDR is involved in tumor angiogenesis as well as cancer cell growth and survival. In this study, we evaluated the therapeutic potential of TTAC-0001, a fully human antibody against VEGFR-2/KDR. To assess the efficacy of the antibody and pharmacokinetic (PK) relationship in vivo, we tested the potency of TTAC-0001 in glioblastoma and colorectal cancer xenograft models. Antitumor activity of TTAC-0001 in preclinical models correlated with tumor growth arrest, induction of tumor cell apoptosis, and inhibition of angiogenesis. We also evaluated the combination effect of TTAC-0001 with a chemotherapeutic agent in xenograft models. We were able to determine the relationship between PK and the efficacy of TTAC-0001 through in vivo single-dose PK study. Taken together, our data suggest that targeting VEGFR-2 with TTAC-0001 could be a promising approach for cancer treatment.

SUBMITTER: Kim DG 

PROVIDER: S-EPMC4966428 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis.

Kim Dong Geon DG   Jin Younggeon Y   Jin Juyoun J   Yang Heekyoung H   Joo Kyeung Min KM   Lee Weon Sup WS   Shim Sang Ryeol SR   Kim Sung-Woo SW   Yoo Jinsang J   Lee Sang Hoon SH   Yoo Jin-San JS   Nam Do-Hyun DH  

mAbs 20150901 6


Vascular endothelial growth factor (VEGF) and its receptors are considered the primary cause of tumor-induced angiogenesis. Specifically, VEGFR-2/kinase insert domain receptor (KDR) is part of the major signaling pathway that plays a significant role in tumor angiogenesis, which is associated with the development of various types of tumor and metastasis. In particular, KDR is involved in tumor angiogenesis as well as cancer cell growth and survival. In this study, we evaluated the therapeutic po  ...[more]

Similar Datasets

| S-EPMC4622656 | biostudies-literature
| S-EPMC1171131 | biostudies-other
| S-EPMC449944 | biostudies-other
| S-EPMC140315 | biostudies-literature
| S-EPMC2914788 | biostudies-literature
| S-EPMC2834394 | biostudies-literature
| S-EPMC3176242 | biostudies-literature
| S-EPMC4259185 | biostudies-literature
| S-EPMC5694508 | biostudies-literature
| 2077752 | ecrin-mdr-crc